4.6 Review

Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype-Phenotype Correlations

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Biochemistry & Molecular Biology

Patients carrying Arg1809 substitution with no choroidal abnormalities: a further proof of a Quasi-Incomplete NF1 phenotype

Claudia Santoro et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Review Medicine, General & Internal

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

Charlotte Carton et al.

Summary: This study aims to integrate information on NF1-associated tumors to assist healthcare professionals in tumor surveillance of NF1 individuals. Personalized and targeted tumor management proposals have been defined to ensure appropriate care for those in need.

ECLINICALMEDICINE (2023)

Review Clinical Neurology

Systemic Review and Meta-analysis of the Intellectual Integrity of Children with Neurofibromatosis Type 1

Faris Abdullah Hamed Al-Farsi et al.

Summary: Children with NF-1 have significantly lower IQ compared to their age-matched peers, with a particular impairment in performance IQ. Tailored educational programs are crucial for these children.

WORLD NEUROSURGERY (2022)

Article Oncology

Choroidal Abnormalities in Pediatric NF1: A Cohort Natural History Study

Eleonora Cosmo et al.

Summary: This study assessed the long-term natural history of choroidal abnormalities (CAs) in pediatric patients with NF1, showing that CAs increase in both number and size over time, independently from the eye's physiological growth.

CANCERS (2022)

Review Biochemistry & Molecular Biology

Mystery(n) Phenotypic Presentation in Europeans: Report of Three Further Novel Missense RNF213 Variants Leading to Severe Syndromic Forms of Moyamoya Angiopathy and Literature Review

Claudia Santoro et al.

Summary: This study identified rare variants in the RNF213 gene that cause Moyamoya angiopathy (MMA) in European children. These variants lead to a syndromic form of early-onset, bilateral MMA with elevated aminotransferases and extracerebral vascular involvement, alongside distinctive skin manifestations.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

Peter M. K. de Blank et al.

Summary: Neurofibromatosis type 1 (NF1) is a genetic syndrome with a wide range of clinical manifestations driven by overactivation of the RAS pathway. Mitogen-activated protein kinase kinase inhibitors (MEKi) can block downstream targets of RAS. The recent approval of MEKi selumetinib for inoperable symptomatic plexiform neurofibromas in children with NF1 has made it the first medical therapy approved for this indication. Clinical trials have shown potential benefits of MEKi for various other NF1 manifestations, and there is interest in their clinical use.

NEURO-ONCOLOGY (2022)

Article Oncology

NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat

Amedeo A. Azizi et al.

Summary: A multidisciplinary expert group identified risk factors associated with visual progression in pediatric patients with neurofibromatosis type 1 associated optic pathway glioma. Factors such as multiple visual signs and symptoms, abnormal visual behavior, and optic atrophy were found to be predictive of poor visual outcomes in these children.

NEURO-ONCOLOGY (2021)

Review Oncology

Vision Outcomes for Pediatric Patients With Optic Pathway Gliomas Associated With Neurofibromatosis Type I: A Systematic Review of the Clinical Evidence

Vineeth M. Thirunavu et al.

Summary: Children with NF1 have a higher likelihood of developing OPGs, which can lead to visual deterioration. Different treatment strategies for OPG-NF1, including observation, chemotherapy, radiation therapy, and surgery, have varying impacts on vision outcomes. While observation showed stable acuity in the majority of patients, chemotherapy had mixed results and radiation/surgery led to worsening acuity in a higher percentage of cases. Further research is needed to determine the best approach for managing OPG-NF1 and its impact on vision outcomes.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)

Review Oncology

Cutaneous Findings in Neurofibromatosis Type 1

Bengisu Ozarslan et al.

Summary: Neurofibromatosis type 1 (NF1) is a complex autosomal dominant disorder with a wide range of clinical manifestations and complications. There is still no specific treatment defined, requiring a multidisciplinary approach for optimal care.

CANCERS (2021)

Review Peripheral Vascular Disease

Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS)

Ramya Sivasubramanian et al.

Summary: This review highlights the association between Turner syndrome, neurofibromatosis type 1, and William syndrome with an increased risk of hypertension. It discusses the clinical manifestations and management of hypertension in children and adolescents with these genetic conditions. Vigilant monitoring, early accurate diagnosis, and management of hypertension are recommended to delay or prevent target organ damage among these patients.

CURRENT HYPERTENSION REPORTS (2021)

Review Genetics & Heredity

Atypical NF1 Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large NF1 Deletions

Hildegard Kehrer-Sawatzki et al.

Summary: Patients with neurofibromatosis type 1 (NF1) and type 1 NF1 deletions exhibit more severe clinical manifestations. Type 1 NF1 deletions involve loss of 14 protein-coding genes, including NF1 and SUZ12. Atypical NF1 deletions, which do not encompass all 14 protein-coding genes, may contribute to understanding the genotype/phenotype relationship in patients with NF1 microdeletions.
Article Genetics & Heredity

A novel MEIS2 mutation explains the complex phenotype in a boy with a typical NF1 microdeletion syndrome

Claudia Santoro et al.

Summary: This study presents a clinical case of a boy with NF1 microdeletion syndrome, cleft palate, dysmorphic features, hypoplasia of corpus callosum, and bicoronal craniosynostosis caused by a novel MEIS2 gene mutation inherited from the father. The inherited MEIS2 mutation is only the second reported case to date, suggesting a potential role of this gene in cranial morphogenesis in humans.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2021)

Article Medicine, General & Internal

Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020

Jace P. Landry et al.

Summary: This study investigated the prevalence of neoplasms and outcomes among patients with NF1, finding that these patients develop various tumors at a younger age and more frequently than the general population. Patients with certain neoplasms like undifferentiated pleomorphic sarcoma, high-grade glioma, and malignant peripheral nerve sheath tumor had significantly lower disease-specific survival rates.

JAMA NETWORK OPEN (2021)

Article Genetics & Heredity

Clinical variability of neurofibromatosis 1: A modifying role of cooccurring PTPN11 variants and atypical brain MRI findings

Alessandra D'Amico et al.

Summary: This study identified functionally relevant PTPN11 variants in a small proportion of NF1 patients, suggesting a new disease mechanism where disease presentation is modified by dysregulation of proteins linked to neurofibromin. Targeting SHP2 function may be a potential approach to treat progressive complications of NF1.

CLINICAL GENETICS (2021)

Article Genetics & Heredity

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

Eric Legius et al.

Summary: The study revised the diagnostic criteria for neurofibromatosis type 1 (NF1) and established criteria for Legius syndrome (LGSS) by combining major developments in genetics, ophthalmology, dermatology, and neuroimaging. Consensus on minimal clinical and genetic criteria for diagnosing and differentiating NF1 and LGSS was reached, with recommendations for mosaic forms of these conditions. Continued refinement of these new criteria will be necessary to study their diagnostic properties, reconsider criteria not included, and identify new features of the conditions, hence proposing an initiative to periodically update the diagnostic criteria for NF1 and LGSS.

GENETICS IN MEDICINE (2021)

Review Genetics & Heredity

Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions

Hildegard Kehrer-Sawatzki et al.

Summary: Among patients with NF1, 5-11% have large deletions called NF1 microdeletions, with type-1 NF1 deletions being the most common and associated with specific clinical features. Genes within the type-1 NF1 microdeletion interval act as modifiers for the disease phenotype, thereby causing the NF1 microdeletion syndrome. Genotype/phenotype correlations in NF1 microdeletion patients are important for identifying genes responsible for the syndrome.

HUMAN GENETICS (2021)

Article Genetics & Heredity

Genotype-Phenotype Associations in Patients With Type-1, Type-2, and Atypical NF1 Microdeletions

Gergely Buki et al.

Summary: Neurofibromatosis type 1 (NF1) microdeletion patients exhibit a more severe clinical phenotype, with common features including dysmorphic facial features, macrocephaly, and large hands and feet, occurring more frequently compared to patients with intragenic NF1 mutations. The study found that 70% of patients had type-1 deletion, 23% had atypical NF1 deletion, with neurobehavior problems, macrocephaly, and overgrowth less frequent in atypical cases.

FRONTIERS IN GENETICS (2021)

Article Health Care Sciences & Services

Natural History of Scoliosis in Children with NF1: An Observation Study

Giuseppe Toro et al.

Summary: This study reviewed records of 438 patients with NF1 and scoliosis, and found that male NF1 patients are more prone to scoliosis requiring surgery.

HEALTHCARE (2021)

Review Clinical Neurology

An update on the central nervous system manifestations of neurofibromatosis type 1

J. Stephen Nix et al.

ACTA NEUROPATHOLOGICA (2020)

Review Genetics & Heredity

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

Christina Bergqvist et al.

ORPHANET JOURNAL OF RARE DISEASES (2020)

Article Dermatology

Cafe au lait spots: When and how to pursue their genetic origins

Leah Lalor et al.

CLINICS IN DERMATOLOGY (2020)

Article Endocrinology & Metabolism

Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study

Claudia Santoro et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Clinical Neurology

Neurofibromatosis type 1-related hydrocephalus: causes and treatment considerations

Jonathan Roth et al.

CHILDS NERVOUS SYSTEM (2020)

Review Clinical Neurology

Epilepsy in NF1: a systematic review of the literature

Pia Bernardo et al.

CHILDS NERVOUS SYSTEM (2020)

Review Clinical Neurology

Neurofibromatosis 1-associated optic pathway gliomas

Ben Shofty et al.

CHILDS NERVOUS SYSTEM (2020)

Article Clinical Neurology

Spinal manifestations of Neurofibromatosis type 1

Ben Shofty et al.

CHILDS NERVOUS SYSTEM (2020)

Letter Clinical Neurology

Epilepsy surgery in neurofibromatosis type 1: an overlooked therapeutic approach

Pia Bernardo et al.

CHILDS NERVOUS SYSTEM (2020)

Letter Genetics & Heredity

Growth hormone excess in neurofibromatosis 1

Fady Hannah-Shmouni et al.

GENETICS IN MEDICINE (2019)

Article Genetics & Heredity

Prevalence of neurofibromatosis type 1 in the Finnish population

Roope A. Kallionpaa et al.

GENETICS IN MEDICINE (2018)

Article Clinical Neurology

Optic Pathway Gliomas in Neurofibromatosis Type 1

Cynthia J. Campen et al.

JOURNAL OF CHILD NEUROLOGY (2018)

Article Pediatrics

Pediatric neuro MRI: tricks to minimize sedation

Matthew J. Barkovich et al.

PEDIATRIC RADIOLOGY (2018)

Article Pediatrics

Medullary unidentified bright objects in Neurofibromatosis type 1: a case series

Alessandra D'Amico et al.

BMC PEDIATRICS (2018)

Article Oncology

A brief report of plexiform neurofibroma

Mandi Khajavi et al.

CURRENT PROBLEMS IN CANCER (2018)

Review Genetics & Heredity

Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes

Parisa Sharafi et al.

JOURNAL OF NEUROGENETICS (2018)

Article Pediatrics

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?

Claudia Santoro et al.

ITALIAN JOURNAL OF PEDIATRICS (2018)

Article Respiratory System

Pulmonary hypertension associated with neurofibromatosis type 1

Etienne-Marie Jutant et al.

EUROPEAN RESPIRATORY REVIEW (2018)

Review Genetics & Heredity

Emerging genotype-phenotype relationships in patients with large NF1 deletions

Hildegard Kehrer-Sawatzki et al.

HUMAN GENETICS (2017)

Article Dermatology

The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study

Carmen Liy-Wong et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Article Medicine, General & Internal

Neurofibromatosis type 1

David H. Gutmann et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Pediatrics

Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1

Martha Milade Torres Nupan et al.

FRONTIERS IN PEDIATRICS (2017)

Review Clinical Neurology

Neurodevelopmental disorders in children with neurofibromatosis type 1

Alecia C. Vogel et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2017)

Article Genetics & Heredity

Growth hormone excess in children with neurofibromatosis type-1 and optic glioma

Paola Cambiaso et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)

Article Genetics & Heredity

Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience

Claudia G Santoro et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)

Article Clinical Neurology

Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1

Ji Hoon Phi et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2016)

Article Multidisciplinary Sciences

The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation

Theresia Dunzendorfer-Matt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Letter Biochemistry & Molecular Biology

Arg1809 substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1

Claudia Santoro et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2015)

Article Biochemistry & Molecular Biology

p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas

Valentina Pinna et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2015)

Article Genetics & Heredity

LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies

Claudia Santoro et al.

BMC MEDICAL GENETICS (2014)

Article Oncology

Malignant Peripheral Nerve Sheath Tumors

Mohamad Farid et al.

ONCOLOGIST (2014)

Article Clinical Neurology

Neurofibromatosis Type 1 Associated With Moyamoya Syndrome in Children

Anna Duat-Rodriguez et al.

PEDIATRIC NEUROLOGY (2014)

Article Geriatrics & Gerontology

Autopsy case of concurrent Huntington's disease and neurofibromatosis type 1

Ito Kawakami et al.

PSYCHOGERIATRICS (2014)

Article Dentistry, Oral Surgery & Medicine

Down syndrome and neurofibromatosis: a case report

Rebecca Schaffer et al.

SPECIAL CARE IN DENTISTRY (2014)

Review Genetics & Heredity

The RASopathies

Katherine A. Rauen

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 14 (2013)

Review Clinical Neurology

Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence

Annukka Lehtonen et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2013)

Article Biochemistry & Molecular Biology

Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation

Shay Ben-Shachar et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2013)

Article Endocrinology & Metabolism

Elevated Head Circumference-to-Height Ratio Is an Early and Frequent Feature in Children with Neurofibromatosis Type 1

Marjo Karvonen et al.

HORMONE RESEARCH IN PAEDIATRICS (2013)

Article Clinical Neurology

Height Assessments in Children With Neurofibromatosis Type 1

Elizabeth A. Soucy et al.

JOURNAL OF CHILD NEUROLOGY (2013)

Article Clinical Neurology

Spectrum and Prevalence of Vasculopathy in Pediatric Neurofibromatosis Type 1

Bonnie Kaas et al.

JOURNAL OF CHILD NEUROLOGY (2013)

Article Dermatology

Nevus anemicus in neurofibromatosis type 1: A potential new diagnostic criterion

Myriam Marque et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)

Article Pathology

A Highly Sensitive Genetic Protocol to Detect NF1 Mutations

Maria Carmen Valero et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2011)

Article Genetics & Heredity

Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service

D. G. Evans et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)

Article Clinical Neurology

Cognitive Profile of Children with Neurofibromatosis and Reading Disabilities

Laurie E. Cutting et al.

CHILD NEUROPSYCHOLOGY (2010)

Article Genetics & Heredity

Independent NF1 and PTPN11 Mutations in a Family With Neurofibromatosis-Noonan Syndrome

Christian Thiel et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)

Review Cell Biology

The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation

William E. Tidyman et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)

Review Medicine, General & Internal

MEDICAL PROGRESS Moyamoya Disease and Moyamoya Syndrome

R. Michael Scott et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Pediatrics

Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1

Jose Roberto Lopes Ferraz Filho et al.

PEDIATRIC RADIOLOGY (2008)

Article Genetics & Heredity

Increased dental caries in people with neurofibromatosis 1

Tracey Tucker et al.

CLINICAL GENETICS (2007)

Article Genetics & Heredity

Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification

A. De Luca et al.

JOURNAL OF MEDICAL GENETICS (2007)

Article Genetics & Heredity

NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome

A De Luca et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2005)

Article Clinical Neurology

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1)

JS Guillamo et al.

Review Genetics & Heredity

Cardiovascular disease in neurofibromatosis 1: Report of the NF1 cardiovascular task force

JM Friedman et al.

GENETICS IN MEDICINE (2002)

Article Genetics & Heredity

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

DGR Evans et al.

JOURNAL OF MEDICAL GENETICS (2002)

Article Medicine, General & Internal

Frequency of choroidal abnormalities in neurofibromatosis type 1

T Yasunari et al.

LANCET (2000)

Article Pediatrics

Renovascular disease and hypertension in children with neurofibromatosis

E Fossali et al.

PEDIATRIC NEPHROLOGY (2000)